CAI
Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$29.98
−3.04%Forward multiples
Based on analyst estimates
- P/E forward
- 118.51x
- P/E 2026E
- 248.95x
- P/E 2027E
- 85.10x
- P/E 2028E
- 56.21x
- P/S forward
- 7.61x
Trailing multiples
Trailing twelve months
- P/E TTM
- 80.61x
- PEG TTM
- —
- Price / book
- 14.32x
- Price / sales
- 8.56x
- Price / cash flow
- 42.06x
Enterprise value
- Enterprise value
- $8.1B
- EV / sales
- 8.22x
- EV / EBITDA
- 47.09x
- EV / EBIT
- 53.06x
- Market cap
- $8.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026